Skip to main content

carmustine

Generic: CARMUSTINE·Brand: BICNU, BiCNU, CARMUSTINE, GLIADEL

carmustine: 3 clinical trials tracked.

carmustine evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about carmustine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 2 study sponsors
Clinical Trials (3)

A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)

NCT06915246·Phase 2·VVUS
Recruiting

Primary endpoint: Evaluation of infusion-related toxicities

InterventionalRandomizedopen49 targetStarted 2025-03Completion 2027-044 sites · United StatesVIVUS LLC

A Three-part, Phase I/II Dose-Escalation Study to Define the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 With Subsequent Extension of Optimal Dose in Recurrent GBM Subjects

NCT03382977·Phase 1/Phase 2·VBIV
Terminated

Primary endpoint: Dose limiting toxicity (DLT) occurring during Part A of the study

Interventionalopen70 targetStarted 2017-12Completion 2025-0812 sites · United StatesVBI Vaccines Inc.

A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542·Phase 2
Active, not recruiting

Primary endpoint: progression-free survival (PFS)

InterventionalRandomizedopen59 targetStarted 2015-10Completion 2026-1014 sites · United StatesMemorial Sloan Kettering Cancer Center